Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125303791 | 12530379 | 1 | I | 20160624 | 20160706 | 20160706 | EXP | US-LUPIN PHARMACEUTICALS INC.-2016-02953 | LUPIN | QURESHI M, CATALASAN G. THE USE OF HIGH DOSE INSULIN EUGLYCEMIA THERAPY IN CALCIUM CHANNEL BLOCKER AND BETA BLOCKER OVERDOSE. THE JOURNAL OF GENERAL INTERNAL MEDICINE. 2016;31(S1)(2):S760-S761. | 48.00 | YR | M | Y | 0.00000 | 20160706 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125303791 | 12530379 | 1 | PS | CARVEDILOL. | CARVEDILOL | 1 | Unknown | OVERDOSE | UNKNOWN | 78217 | |||||||||
| 125303791 | 12530379 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | OVERDOSE | UNKNOWN | 78043 | |||||||||
| 125303791 | 12530379 | 3 | SS | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | OVERDOSE | UNKNOWN | 0 | |||||||||
| 125303791 | 12530379 | 4 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | OVERDOSE | UNKNOWN | 0 | |||||||||
| 125303791 | 12530379 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | Unknown | OVERDOSE | UNKNOWN | 77321 | |||||||||
| 125303791 | 12530379 | 6 | SS | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | OVERDOSE | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125303791 | 12530379 | 1 | Product used for unknown indication |
| 125303791 | 12530379 | 2 | Product used for unknown indication |
| 125303791 | 12530379 | 3 | Product used for unknown indication |
| 125303791 | 12530379 | 4 | Product used for unknown indication |
| 125303791 | 12530379 | 5 | Product used for unknown indication |
| 125303791 | 12530379 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125303791 | 12530379 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125303791 | 12530379 | Acute kidney injury | |
| 125303791 | 12530379 | Cardiomegaly | |
| 125303791 | 12530379 | Hypotension | |
| 125303791 | 12530379 | Overdose | |
| 125303791 | 12530379 | Pulmonary oedema | |
| 125303791 | 12530379 | Shock | |
| 125303791 | 12530379 | Tachycardia | |
| 125303791 | 12530379 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |